The use of positron emission tomography in the clinical assessment of dementia (Q35532399)

8 August 2017

1 reference

title

The use of positron emission tomography in the clinical assessment of dementia (English)

1 reference

positron emission tomography

8 August 2017

1 reference

inferred from title

author

Richard S. J. Frackowiak

series ordinal

2

1 reference

8 August 2017

Mazziotta JC

1

1 reference

PubMed ID

1439869

8 August 2017

Phelps ME

series ordinal

3

1 reference

8 August 2017

1 October 1992

1 reference

Seminars in Nuclear Medicine

8 August 2017

1 reference

8 August 2017

22

1 reference

8 August 2017

233-246

1 reference

8 August 2017

4

1 reference

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Relationships of senile manifestations and chronic brain syndromes to cerebral circulation and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

A subtraction method for determining cerebral blood flow by xenon-133 inhalation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Recent advances in neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Examining the relationship between computed tomography and neuropsychological measures in normal and demented elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cognitive correlates of diffuse cerebral atrophy determined by computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Positron Emission Tomography in the Study of Aging and Senile Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cortical abnormalities in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Wechsler Adult Intelligence Scale performance. Cortical localization by fluorodeoxyglucose F 18-positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Positron emission tomography in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Predominant left hemisphere metabolic dysfunction in dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Regional cerebral glucose transport and utilization in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Positron emission tomography in the early diagnosis of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Positron emission tomography and histopathology in Pick's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Hereditary dysphasic dementia and the Pick-Alzheimer spectrum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

An unusual case of Pick's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Pick's disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Multi-infarct dementia. A cause of mental deterioration in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Localized thalamic hemorrhage A cause of aphasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Aphasia with nonhemorrhagic lesions in the basal ganglia and internal capsule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Various consequences of subcortical stroke. Prospective study of 16 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Aphasia with predominantly subcortical lesion sites: description of three capsular/putaminal aphasia syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Validity of clinical diagnosis in dementia: a prospective clinicopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The clinical diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Comparison of angiographic and CT findings between patients with multi-infarct dementia and those with dementia due to primary neuronal degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

MRI periventricular lesions in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Deep white matter infarction: correlation of MR imaging and histopathologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

An estimate of the incidence of dementia in idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Dementia in Parkinson disease: A neuropathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Parkinson's disease in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Lewy Bodies in the Presence of Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Pneumoencephalography of progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

CT findings in progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Progressive supranuclear palsy and a multi-infarct state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Huntington's disease: New approaches to an old problem: The Robert Wartenberg Lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Huntington's disease. Pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Bicaudate index in computerized tomography of Huntington disease and cerebral atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cerebellum and brain stem atrophy in a child with Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed Tomographic, Neurologic, and Neuropsychological Correlates of Huntington'S Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Bicaudate diameter?the most specific and simple CT parameter in the diagnosis of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed tomography for Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Nuclear magnetic resonance imaging in movement disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Regression model for predicting dissociations of regional cerebral glucose metabolism in individuals at risk for Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Quantitation in positron emission computed tomography: 5. Physical--anatomical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Normal caudate glucose metabolism in persons at risk for Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed tomography in Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Wilson's disease clinical correlation with cranial computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computerized cranial tomography in Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Computed tomography in Wilson disease: report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Wilson's disease studied with FDG and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

The metabolic pathology of the AIDS dementia complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

Mental function and cerebral oxygen consumption in organic dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

7 January 2021

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

7 January 2021

Neuropathologic correlation of computerized tomography in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980118-7

7 January 2021

10.1016/S0001-2998(05)80118-7

Identifiers

DOI

1 reference

8 August 2017

1 reference

PubMed ID

1439869